CD7 and breast cancer: This result may suggest that as in breast cancer [24], subclones interactions participate into tumour growth and the lack of CD7+/CD34+ imprinting on CD7+/CD34− cells may impair the ability of CD7+/CD34− cells to engraft in secondary recipients.